Skip to content
healthcare.dev
Get a free key

TAGRISSO

NDC 0310-1349, osimertinib, tablet, film coated, from AstraZeneca Pharmaceuticals LP.

Product NDC
0310-1349
Status
Listed
Labeler
AstraZeneca Pharmaceuticals LP
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA208065
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0310-1349 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OSIMERTINIB40 mg/1

Pharmacologic classes

Breast Cancer Resistance Protein Inhibitors [MoA]; Cytochrome P450 1A2 Inducers [MoA]; Cytochrome P450 3A Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Kinase Inhibitor [EPC]; Kinase Inhibitors [MoA]

Package NDCNDC-11Package
0310-1349-300031013493030 TABLET, FILM COATED in 1 BOTTLE (0310-1349-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/5e81b4a7-b971-45e1-9c31-29cea8c87ce7

Use it

Look up 0310-1349 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0310-1349 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0310-1349. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.